Structure, morphology, and bioactivity of biocompatible systems derived from functionalized acrylic polymers based on 5-amino-2-naphthalene sulfonic acid

Biomacromolecules

Volumn 11, Issue 7, 2010, Pages 1763-1772

  Garcia Fernandez L ^a,b   Aguilar, M R ^b   Fernandez M M ^c   Lozano, R M ^d   Gimenez G ^d   Valverde, S ^e   San Roman J ^a,b  

^a INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^e CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2-NAPHTHALENE SULFONIC ACID; ACRYLIC POLYMERS; AMPHIPHILIC COPOLYMERS; ANGIOGENIC PROCESS; AVERAGE SIZE; BIO-COMPATIBLE SYSTEMS; BUTYLACRYLATE; CO-POLYMER SYSTEMS; CONCENTRATION OF; CONCENTRATION-DEPENDENT; FIBROBLAST GROWTH FACTOR; FREE RADICAL COPOLYMERIZATION; FUNCTIONALIZED; GROWTH FACTOR; INHIBITORY EFFECT; LOW TOXICITY; METHACRYLAMIDES; POLYDISPERSITY INDICES; POLYMER DRUGS; POLYMERIZATION PROCESS; SELF-ASSEMBLED; SELF-ASSEMBLING; SULFONIC GROUP; THERAPEUTIC STRATEGY; TUMOR ANGIOGENESIS; VASCULAR CELLS; VINYLPYRROLIDONE;

ACIDS; BIOACTIVITY; CELL CULTURE; CELL PROLIFERATION; COPOLYMERIZATION; COPOLYMERS; FIBROBLASTS; FREE RADICALS; GROWTH KINETICS; MACROMOLECULES; MORPHOLOGY; NANOPARTICLES; NAPHTHALENE; PATHOLOGY; PEPTIDES; PLASTIC PRODUCTS; POLYDISPERSITY; POLYMERS; TISSUE;

FUNCTIONAL POLYMERS;

1 VINYL 2 PYRROLIDINONE; ACIDIC FIBROBLAST GROWTH FACTOR; ANTIMITOTIC AGENT; COPOLYMER; FIBROBLAST GROWTH FACTOR; HEPARIN; NANOPARTICLE; POLY(1 VINYL 2 PYRROLIDONE CO 5 METHACRYLAMIDE 2 NAPHTHALENESULFONIC ACID); POLY(BUTYLACRYLATE CO 5 METHACRYLAMIDE 2 NAPHTHALENESULFONIC ACID); POLYACRYLIC ACID; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; MATHEMATICAL COMPUTING; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

3T3 CELLS; ACRYLAMIDES; ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; DRUG CARRIERS; FIBROBLAST GROWTH FACTOR 1; MICE; MICELLES; NANOPARTICLES; NAPHTHALENESULFONATES; NEOVASCULARIZATION, PATHOLOGIC; POLYMERS;

EID: 77955165750     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm100223d     Document Type: Article

References (26)

1. Quesada, A. R.; Oz, C.; Medina, M. A. Anti-angiogenic drugs: From bench to clinical trials Med. Res. Rev. 2006, 26 (4) 483-530
2. Zhong, H.; Bowen, J. P. Antiangiogenesis drug design: Multiple pathways targeting tumor vasculature Curr. Med. Chem. 2006, 13 (8) 849-862
3. Wheatley-Price, P.; Shepherd, F. A. Targeting angiogenesis in the treatment of lung cancer J. Thorac. Oncol. 2008, 3 (10) 1173-1184
4. Petersen, I. Antiangiogenesis, anti-VEGF(R) and outlook. In Targeted Therapies in Cancer; Dietel, M., Ed.; Springer: Berlin., 2007; pp 189 - 199.
5. Auguste, P.; Javerzat, S.; Bikfalvi, A. Regulation of vascular development by fibroblast growth factors Cell Tissue Res. 2003, 314 (1) 157-166
6. Kathir, K. M.; Kumar, T. K. S.; Yu, C. Understanding the mechanism of the antimitogenic activity of suramin Biochemistry 2006, 45 (3) 899-906
7. Schneider, G. P.; Salcedo, R.; Dong, H. F.; Kleinman, H. K.; Oppenheim, J. J.; Howard, O. M. Z. Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1Ǐ Clin. Cancer Res. 2002, 8 (12) 3955-3960
8. Fernández-Tornero, C.; Lozano, R. M.; Redondo-Horcajo, M.; Goìmez, A. M.; Loìpez, J. C.; Quesada, E.; Uriel, C.; Valverde, S.; Cuevas, P.; Romero, A.; Giménez-Gallego, G. Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity. Crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalenesulfonate J. Biol. Chem. 2003, 278 (24) 21774-21781
9. Satchi-Fainaro, R.; Duncan, R.; Barnes, C. M. Polymer Therapeutics for Cancer: Current Status and Future Challenges; Springer: Berlin, 2006; pp 1 - 65.
10. Vicent, M. J.; Duncan, R. Polymer conjugates: Nanosized medicines for treating cancer Trends Biotechnol. 2006, 24 (1) 39-47
11. Duncan, R. Polymer conjugates for tumour targeting and intracytoplasmic delivery. The EPR effect as a common gateway Pharm. Sci. Technol. Today 1999, 2 (11) 441-449
12. Garciiìa-Fernaiìndez, L.; Aguilar, M. R.; Fernaiìndez, M. M.; Lozano, R. M.; Gimeiìnez, G.; Romaiìn, J. S. Antimitogenic polymer drugs based on AMPS: Monomer distribution- bioactivity relationship of water-soluble macromolecules Biomacromolecules 2010
13. Tidwell, P. W.; Mortimer, G. A. An improved method of calculating copolymerization rectivity ratios J. Polym. Sci., Part A: Polym. Chem. 1965, 3, 369-387
14. More, J. J. Levenberg-Marquardt algorithm: implementation and theory; Springer: Berlin, 1977.
15. Kätzel, U.; Bedrich, R.; Stintz, M.; Ketzmerick, R.; Gottschalk-Gaudig, T.; Barthel, H. Dynamic Light Scattering for the Characterization of Polydisperse Fractal Systems: I. Simulation of the Diffusional Behavior Part. Part. Syst. Charact. 2008, 25 (1) 9-18 (Pubitemid 351613112)
16. Hunter, R. J. Foundations of colloid science; Oxford University Press: Oxford, New York, 2001.
17. Moad, G.; Chong, Y. K.; Skidmore, M. A.; Rizzardo, E.; Thang, S. H. Advances in raft polymerization: Improved nanostructured materials, 1st ed.; American Chemical Society, Polymer Preprints, Division of Polymer Chemistry: New Orleans, LA, 2008; pp 293 - 294.
18. Moad, G.; Rizzardo, E.; Thang, S. H. Toward living radical polymerization Acc. Chem. Res. 2008, 41 (9) 1133-1142
19. Moad, G.; Rizzardo, E.; Thang, S. H. Living radical polymerization by the RAFT process: A second update Aust. J. Chem. 2009, 62 (11) 1402-1472
20. Tanford, C. Interfacial free energy and the hydrophobic effect Proc. Natl. Acad. Sci. U.S.A. 1979, 76 (9) 4175-4176
21. Blanazs, A.; Armes, S. P.; Ryan, A. J. Self-assembled block copolymer aggregates: From micelles to vesicles and their biological applications Macromol. Rapid Commun. 2009, 30 (4-5) 267-277
22. LoPresti, C.; Lomas, H.; Massignani, M.; Smart, T.; Battaglia, G. Polymersomes: Nature inspired nanometer sized compartments J. Mater. Chem. 2009, 19 (22) 3576-3590
23. Battaglia, G.; Ryan, A. J. Effect of amphiphile size on the transformation from a lyotropic gel to a vesicular dispersion Macromolecules 2005, 39 (2) 798-805
24. Chiriac, A. P.; Nita, L. E.; Neamtu, I.; Bercea, M. Contribution to polymer nanoparticles analysis by laser light scattering Polym. Test. 2009, 28 (8) 886-890
25. Sun, Z.; Xu, S.; Dai, G.; Li, Y.; Lou, L.; Liu, Q.; Zhu, R. A microscopic approach to studying colloidal stability J. Chem. Phys. 2003, 119 (4) 2399-2405
26. Spivak-Kroizman, T.; Lemmon, M. A.; Dikic, I.; Ladbury, J. E.; Pinchasi, D.; Huang, J.; Jaye, M.; Crumley, G.; Schlessinger, J.; Lax, I. Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation Cell 1994, 79 (6) 1015-1024